Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 12;1(12):564-567.
doi: 10.1253/circrep.CR-19-0104.

Direct Cardiac Reprogramming - Converting Cardiac Fibroblasts to Cardiomyocytes

Affiliations
Review

Direct Cardiac Reprogramming - Converting Cardiac Fibroblasts to Cardiomyocytes

Taketaro Sadahiro. Circ Rep. .

Abstract

Cardiovascular disease is the leading cause of death and disability worldwide. Despite advances in cardiovascular therapy, mortality in heart disease still remains high. Direct cardiac reprogramming is a promising approach for cardiac tissue repair involving in situ generation of new cardiomyocytes from endogenous cardiac fibroblasts. Although, initially, the reprogramming efficiency was low, several developments in reprogramming methods have improved the in vitro cardiac reprogramming efficiency. Subsequently, in vivo cardiac reprogramming has demonstrated improvement in cardiac function and fibrosis after myocardial infarction. Here, we review recent progress in cardiac reprogramming as a new technology for cardiac regeneration.

Keywords: Cardiomyocyte; Direct reprogramming; Fibroblast; Regeneration.

PubMed Disclaimer

Conflict of interest statement

T.S. declares no conflicts of interest.

Figures

Figure.
Figure.
Challenges to generating cardiomyocytes for cardiac regeneration. Myocardial fibrosis was resolved and cardiac function improved after cardiac direct reprogramming. iCM, induced cardiomyocyte-like cells.

References

    1. Furtado MB, Nim HT, Boyd SE, Rosenthal NA.. View from the heart: Cardiac fibroblasts in development, scarring and regeneration. Development 2016; 143: 387–397. - PubMed
    1. Fan D, Takawale A, Lee J, Kassiri Z.. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 2012; 5: 15. - PMC - PubMed
    1. Yoshida Y, Yamanaka S.. Induced pluripotent stem cells 10 years later: For cardiac applications. Circ Res 2017; 120: 1958–1968. - PubMed
    1. Takahashi K, Yamanaka S.. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663–676. - PubMed
    1. Sadahiro T, Yamanaka S, Ieda M.. Direct cardiac reprogramming: Progress and challenges in basic biology and clinical applications. Circ Res 2015; 116: 1378–1391. - PubMed

LinkOut - more resources